Endometrial cancer: open trials in Denmark

• NCT06760819

  A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

  Trial Treatment · Phase 2 · Bayer

  Aarhus University Hospital | Oncology Department - Clinical Research Unit, Aarhus N · Rigshospitalet Copenhagen University Hospital | Oncology Department, Copenhagen · Odense University Hospital | Svendborg Sygehus - Oncology Department, Odense

  Registry updated 2026-11-04

• NCT07166094

  Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

  Trial Treatment · Phase 3 · Genmab

  Aalborg University Hospital, Aalborg

  Registry updated 2026-11-03

• NCT06340568

  A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer

  Trial Treatment · Phase 3 · BioNTech SE

  Aalborg University Hospital, Aalborg · Rigshospitalet, Copenhagen Oe · Region Hovedstaden, Herlev · Odense University Hospital, Odense C · Zealand Pharma A/S, Soeborg

  Registry updated 2026-10-16

• NCT06952504

  A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  Aalborg University Hospital, Aalborg · Region Midtjylland, Aarhus N · Region Hovedstaden, Herlev · Region Sjaelland, Roskilde

  Registry updated 2026-10-13

• NCT06989112

  DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

  Trial Treatment · Phase 3 · AstraZeneca

  Aalborg University Hospital, Aalborg · Rigshospitalet, Copenhagen Oe · Odense University Hospital, Odense C

  Registry updated 2026-10-13

• NCT06276491

  Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

  Trial Treatment · Phase 1 · Xencor, Inc.

  Herlev & Gentofte Hospital, Herlev

  Registry updated 2026-10-09

• NCT06997029

  A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors

  Trial Treatment · Phase 1 · Bristol-Myers Squibb

  Rigshospitalet, Copenhagen Oe · Odense University Hospital, Odense C

  Registry updated 2026-10-06

• 2025-524160-38-00

  A clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  Region Hovedstaden, Herlev

  Registry updated 2026-10-01

• NCT07213609

  A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

  Trial Treatment · Phase 1/2 · GlaxoSmithKline

  København Ø

  Registry updated 2026-09-16

• 2024-519818-31-01

  Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator’s Choice in Participants With Endometrial Cancer ( RAINFOL-03 )

  Trial Treatment · Phase 3 · Genmab A/S

  Aalborg University Hospital, Aalborg · Region Hovedstaden, Herlev · Region Midtjylland, Herning

  Registry updated 2026-08-10

• NCT07044336

  Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

  Trial Treatment · Phase 3 · AstraZeneca

  Herlev Hospital, Herlev · Odense University Hospital, Odense C

  Registry updated 2026-07-29

• NCT07400835

  Evaluation of DNA Methylation Markers for Endometrial Cancer Risk-stratification Using Patient-collected Urine and Vaginal Samples and Clinician-collected Cervical Samples From Women With Postmenopausal Bleeding

  Research · University of Aarhus

  Department of Obstetrics and Gynaecology, Aarhus University Hospital, Aarhus N · Department of Obstetrics and Gynaecology, Odense University Hospital, Odense · Department of Obstetrics and Gynaecology, Randers Regional Hospital, Randers

  Registry updated 2026-05-13

• NCT06846775

  The Clinical Utility of DNA Methylation Testing in Patient-collected Urine and Vaginal Samples to Detect Endometrial Cancer: a Case-control Study

  Research · University of Aarhus

  Department of Obstetrics and Gynaecology, Aarhus University Hospital, Aarhus N · Department of Obstetrics and Gynaecology, Odense University Hospital, Odense · Department of Orthopaedics, Randers Regional Hospital, Randers

  Registry updated 2026-01-26

• NCT05797831

  Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

  Trial Treatment · Phase 2/3 · Kartos Therapeutics, Inc.

  Odense University Hospital, Odense

  Registry updated 2024-05-02

All Endometrial cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error